In vitro assessment of the immobilized mannanase enzyme against infection-causing Candida
Abstract
Background: Developing an effective treatment for fungal infections is among contemporary medicine's challenges. In this study we aimed to eradicate mannan in pathogenic Candidae's cell walls using a nontoxic method, mannanase. Materials & Methods: We investigated the in vitro antifungal activities of mannanase immobilized on zinc oxide nanoparticles (ZnONps) and reduced graphene oxide nanoparticles (RGONps), as well as therapeutics against Candidae. Mannanase was purified from Bacillus invictae (activity: 5.15 EU/ml; range: 60–80%) and then immobilized it to ZnO and RGO to enhance its effectiveness. Results: Mannanase immobilized on ZnONps had the highest activity, with a value of 4.97 EU/ml, more effective than amphotericin-B. However, it could not reach the inhibition rates of other antifungals. Conclusion: Mannanase immobilized on ZnONps could be an effective fungicide for Candida biocontrol.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. AAPS Pharm. Sci. 5(1), E5 (2003).
- 2. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infect. Dis. 21(1), 523 (2021). • Interesting article on the prevalence and antifungal susceptibility of Candida albicans.
- 3. . Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 23(2), 550–563 (2016).
- 4. . Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur. J. Obstet. Gynecol. Reprod. Biol. 126(1), 121–125 (2006).
- 5. . Bacterial vaginosis and desquamative inflammatory vaginitis: choice of an effective therapy method. Review. Science Healthcare 24(4), 216–223 (2022).
- 6. Efficacy and safety of oral administration of a product based on hydroxytyrosol as preventive therapy for recurrent vulvo-vaginal candidosis: a prospective observational pilot study. Eur. Rev. Med. Pharmacol. Sci. 24(13), 7427–7432 (2020).
- 7. . Prevalence of vaginal yeast infections in pregnant and non-pregnant women attending at Gynecology and Obstetrics Department of the tertiary care center in Central region of Nepal. Microbe. Infect. Dis. 4(1), 225–230 (2022).
- 8. . Biocontrol of Candida albicans by antagonistic microorganisms and bioactive compounds. Antibiotics (Basel) 11(9), 1238 (2022).
- 9. . Drug repurposing in medical mycology: identification of compounds as potential antifungals to overcome the emergence of multidrug-resistant fungi. Pharmaceuticals (Basel) 14(5), 488 (2021).
- 10. . Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis. J. Prosthet. Dent. 125(2), 257–265 (2021).
- 11. . Interesting antifungal drug targets in the central metabolism of Candida albicans. Trends Pharmacol Sci 43(1), 69–79 (2022).
- 12. . Mannan in Candida albicans: Various properties and importance. Cerrahpasa Med J 35(1), 1–11 (2014).
- 13. . Production, purification and characterization of mannanase obtained from Pichia kudriavzevii strain AUMC 10190 isolated from citrus wastes. World News Nat. Sci. 45, 1–17 (2022).
- 14. . Applications of microbial beta-mannanases. Front. Bioeng. Biotechnol. 8, 598630 (2020).
- 15. Coproduction of protease and mannanase from Bacillus nealsonii PN-11 in solid state fermentation and their combined application as detergent additives. Int. J. Biol. Macromol. 108, 1176–1184 (2018).
- 16. . Bio-chemical characterization of a β-mannanase from Bacillus licheniformis HDYM-04 isolated from flax water-retting liquid and its decolorization ability of dyes. RSC Adv. 6(28), 23612–23621 (2016).
- 17. Enhancement of beta-mannanase production by Bacillus subtilis ATCC11774 through optimization of medium composition. Molecules 25(15), 3516 (2020).
- 18. . Enhanced beta-mannanase production by Bacillus licheniformis by optimizing carbon source and feeding regimes. Prep. Biochem. Biotechnol. 52(7), 845–853 (2022).
- 19. A novel thermostable GH5_7 beta-mannanase from Bacillus pumilus GBSW19 and its application in manno-oligosaccharides (MOS) production. Enzyme Microb. Technol. 78, 1–9 (2015).
- 20. . Characterization and high-efficiency secreted expression in Bacillus subtilis of a thermo-alkaline beta-mannanase from an alkaliphilic Bacillus clausii strain S10. Microb. Cell Fact 17(1), 124 (2018).
- 21. Impact of immobilization technology in industrial and pharmaceutical applications. 3 Biotech 9(12), 440 (2019).
- 22. Enzyme immobilized in BioMOFs: facile synthesis and improved catalytic performance. Int. J. Biol. Macromol. 144, 19–28 (2020).
- 23. . Bacterial chitinase biochemical properties, immobilization on zinc oxide (ZnO) nanoparticle and its effect on Sitophilus zeamais as a potential insecticide. World J. Microbiol. Biotechnol. 37(10), 173 (2021).
- 24. . Role of zinc oxide nanoparticles in countering negative effects generated by cadmium in Lycopersicon esculentum. J. Plant Growth Regulat. 40(1), 101–115 (2021).
- 25. . Immobilized laccase on zinc oxide nanoarray for catalytic degradation of tertiary butyl alcohol. J. Hazard. Mater. 411, 125104 (2021).
- 26. . Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food Bioprocess. Technol. 5(5), 1447–1464 (2012).
- 27. . In vitro evaluation of effects of different properties of ZnO nanoparticles on fibroblast cell. Anadolu University (2010).
- 28. . Graphene and graphene oxide: functionalization and nano-bio-catalytic system for enzyme immobilization and biotechnological perspective. Int. J. Biol. Macromol. 120(Pt B), 1430–1440 (2018).
- 29. . Lipase immobilized graphene oxide biocatalyst assisted enzymatic transesterification of Pongamia pinnata (Karanja) oil and downstream enrichment of biodiesel by solar-driven direct contact membrane distillation followed by ultrafiltration. Fuel Process. Technol. 211, 106577 (2020).
- 30. . A review on green synthesis, biomedical applications, and toxicity studies of ZnO NPs. Bioinorg. Chem. Appl. 2018, 3569758 (2018).
- 31. . Mannanase activity produced through fermentation of coconut flour at various pH by Aspergilus niger. J. Phys. 1242, 012009 (2019).
- 32. . Facile green synthesis of ZnO-RGO nanocomposites with enhanced anticancer efficacy. Methods 199, 28–36 (2022). •• Important paper describing how the green synthesis of ZnO-RGO nanoparticles was performed.
- 33. . Immobilization and kinetics of catalase on calcium carbonate nanoparticles attached epoxy support. Appl. Biochem. Biotechnol. 172(1), 115–130 (2014).
- 34. . A novel polyurethane/nano ZnO matrix for immobilization of chitinolytic enzymes and optical sensing of chitin. Int. J. Biol. Macromol. 106, 1173–1183 (2018).
- 35. . New technique for ultra-thin serial brain section imaging using scanning electron microscopy. Microscopy Microanalysis 13(S02), 26–27 (2007).
- 36. . Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 55(1), 25–36 (2007).
- 37. . Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991. J. Clin. Microbiol. 37(5), 1625–1627 (1999).
- 38. . Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method. Indian J. Pathol. Microbiol 57(4), 595–597 (2014). •• Very important article describing the evaluation of antifungal organism tests in Candida isolates by Candifast and disk diffusion method.
- 39. . Enzyme immobilization: an overview on nanoparticles as immobilization matrix. Biochem. Analyt. Biochem. 4(3), 178 (2015).
- 40. . TG/FTIR analysis on co-pyrolysis behavior of PE, PVC and PS. Waste Manag. 34(3), 676–682 (2014).
- 41. . Electrochemical heavy metal detection, photocatalytic, photoluminescence, biodiesel production and antibacterial activities of Ag–ZnO nanomaterial. Mater. Res. Bull. 94, 54–63 (2017).
- 42. . Gas sensing behaviour of green synthesized reduced graphene oxide (rGO) for H2 and NO. Mater Lett 236, 444–447 (2019).
- 43. . Categorizing susceptibility of clinical isolates of Candida auris to amphotericin B, caspofungin, and fluconazole by use of the CLSI M44-A2 disk diffusion method. J. Clin. Microbiol. 59(4), e02355-20 (2021).
- 44. . Antimicrobial activity of graphite oxide doped with silver against Bacillus subtilis, Candida albicans, Escherichia coli, and Staphylococcus aureus by agar well diffusion test: synthesis and characterization. Mater. Sci. Eng. C. Mater. Biol. Appl. 123, 111934 (2021).
- 45. . Phytase immobilization on hydroxyapatite nanoparticles improves its properties for use in animal feed. Appl. Biochem. Biotechnol. 190(1), 270–292 (2020).
- 46. . Immobilization of mannanase on sodium alginate-grafted-beta-cyclodextrin: an easy and cost effective approach for the improvement of enzyme properties. Int. J. Biol. Macromol. 156, 1347–1358 (2020).
- 47. . Characterization of β-mannanase extracted from a novel Streptomyces species Alg-S25 immobilized on chitosan nanoparticles. Biotechnol. Biotechnol. Equip. 35(1), 150–161 (2021). • An interesting article in terms of immobilization of mannanase.
- 48. . Covalent immobilization of phytase on the multi-walled carbon nanotubes via diimide-activated amidation: structural and stability study. Artif. Cells Nanomed. Biotechnol. 46(sup1), 763–772 (2018).
- 49. . Advances in graphene oxide based nanobiocatalytic technology for wastewater treatment. Environment. Nanotechnol. Monit. Manag. 17, 100647 (2022).
- 50. Improved enzymatic activity by oriented immobilization on graphene oxide with tunable surface heterogeneity. Composites Part B: Eng. 216, 108788 (2021).
- 51. . [Isolation and characterization of microorganisms with mannanase activity]. Prikl. Biokhim. Mikrobiol. 16(4), 578–583 (1980).
- 52. Biofilm inhibition in Candida albicans with biogenic hierarchical zinc-oxide nanoparticles. Biomater. Adv. 134, 112592 (2022).
- 53. Impediment to growth and yeast-to-hyphae transition in Candida albicans by copper oxide nanoparticles. Biofouling 36(1), 56–72 (2020).
- 54. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 30(31), 6333–6340 (2009).
- 55. . Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int. J. Pharm. 523(1), 15–32 (2017).
- 56. . Solid lipid nanoparticles for hydrophilic drugs. J. Control. Release 335, 457–464 (2021).
- 57. . Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.. Drug Deliv. 24(1), 40–50 (2017).